Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants https://t.co/zL6vh9TWq3
Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2022 – Dec 2025Where it's discussed
-
X / Twitter223 posts
-
Bluesky11 posts
-
News10 articles
-
Facebook4 posts
-
YouTube3 videos
-
Reddit3 posts
AI synopsis
What people are saying
Numerous posts indicate a strong endorsement for the use of nattokinase, with comments like 'Looks really nice and love the emphasis on the holistic approach' reflecting positive sentiments. Others share personal anecdotes, such as one participant stating, 'Got blood work with triglyceride #. W/in the week I started taking 12,000 FU immediately', illustrating deep engagement with the content. Phrases like 'effective management' and 'reversal of carotid artery plaque' highlight the perceived importance of the study, while some mention 'no adverse effects reported', which positively frames their discussions about the research.
Most discussions reflect a positive reception of the publication's findings, with participants generally supportive of nattokinase's benefits.
The overall curiosity about how nattokinase can potentially improve cardiovascular health is evident in the discussions, showcasing high interest levels.
While many participants share their personal experiences with nattokinase, the discussions vary in depth, with some merely skimming the surface rather than exploring the study in detail.
There is a strong belief among participants that the findings of the study could have significant implications for cardiovascular health management.
Abstract in brief
- A clinical study with 1062 participants found that nattokinase (NK) at a dose of 10800 FU/day significantly managed atherosclerosis and hyperlipidemia, improving the lipid profile and reducing carotid artery thickness.
- The lower dose of 3600 FU/day was ineffective for lipid reduction and atherosclerosis progression, while NK's effects were enhanced in individuals with higher BMI or lifestyle factors like smoking and alcohol use.
- Co-administration of vitamin K2 and aspirin with NK showed synergistic benefits, and no adverse effects were reported, challenging previous dosage recommendations.
Top posts
Most liked on X and BlueskySources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
I take 10,000 units a day NOT A RECOMMENDATION. talk to your doctor and as always, get blood work done. https://t.co/zL6vh9TWq3
Doses below 3,600 FU/day were deemed ineffective in limiting atherosclerosis progression. Regular exercise was associated with an enhanced response to nattokinase, and no notable adverse effects were identified (https://t.co/nA9ospxBqj).
#NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adverse effects recorded in 12 months of use. Indicated together with Aspirin 100mg/d it has a synergistic effect also with Vitamin K 180ug/d https://t.co/dlmxg2UYGH https://t.co/yOIg2YWCmG
Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participantes - PubMed https://t.co/TzY8P12owe
All mentions
Transform Your Circulation: Top Foods for Healthy Arteries
Discover 10 amazing foods that can transform your circulation and potentially clean up to 95.6% of your blood vessels. This video discusses essential supplements and vitamins that improve circulation, along with…
Nattokinase: Breakthrough Supplement For Heart Health?
Suplement zamiast STATYN? Cofanie MIAŻDŻYCY, obniżenie ciśnienia, obniżenie cholesterolu i więcej
Nattokinase's Impact on Blood Pressure and Cardiovascular Risk
The study found that consuming nattokinase, a fermented soy extract, can reduce blood pressure in hypertensive individuals, especially in males, and decrease cardiovascular risk markers like von Willebrand factor…
The Nattokinase Breakthrough: Cleanse Your Blood Clots Fast!
Little Known Secret Food That Melts Clogged Arteries Fast!
Nattokinase and Heart Health: Effects on Blood Pressure and Cholesterol
This systematic review analyzed six clinical trials on nattokinase, an enzyme from fermented soy, revealing potential benefits in lowering blood pressure and modifying cholesterol levels. It appears safe with minimal…
Natural Strategies to Reduce Arterial Plaque and Improve Heart Health
This video discusses how diet, lifestyle, and supplements can help stop or even reverse artery plaque development. Scientific studies show natural products may support arterial cleansing and cardiovascular health.
Наттокиназа - лучшая добавка для сердца и сосудов? Кардиомагнил больше не нужен?
Cosa succede al tuo cuore quando assumi Nattokinasi
Carnivore SHOCKS Doctor - Here's What You Need to Know...
Heart Disease TREATMENT - 36% Decrease in Arterial Plaque | THIS MIGHT SAVE YOUR LIFE!
High Dose Nattokinase: 7 Heart Health Benefits! #Nattokinase #HeartHealth
Unlock the Power of Natto Nutrition #nato
This Enzyme Could Help REDUCE Arterial Plaque by 36%!
Nattokinase Can Unclog Blocked Arteries Naturally Without Surgery (Human Research)
Nattokinase and Plaque reduction
Health Benefits of Natto The ???? Japanese Superfood That'll Change Your Life ????#superfood
Nattokinase: Breakthrough Supplement For Heart Health?
Indoktrinirani vernik verjudete Schulmedizin
@itsdratalwar @BarbaraOneillAU https://t.co/VHUzwhwiVS
@PeterJAnderson_ @Paddy_Barrett Nattokinase? https://t.co/2DY661oMNf
@cremieuxrecueil Nattokinase, no? https://t.co/2DY661oeXH
@CY_Chauprade @KevinMcCairnPhD @JCMTA_xiaolin @CoyoteSanctuary Looks really nice and Love the emphasis on the holistic approach. Is there any consideration for nattokinase, or is it considered a phytokene, or perhaps too risky? https://t.co/8s0p27YkgB
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants https://t.co/B1vhVp1sXF
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @realPatrickJr: Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
Sources: https://t.co/CgQulFzGSQ https://t.co/x7vMhgyrED
RT @nateyamasaki: Stockpiled Natto today - Still supplement Nattokinase 12K FU daily. Enhanced athlete benefits → Reduces clot risk →…
Stockpiled Natto today - Still supplement Nattokinase 12K FU daily. Enhanced athlete benefits → Reduces clot risk → Lowers blood pressure → Improves cholesterol profile ⚠️ If on blood thinners check with your MD https://t.co/zQBeMG7YWB https://t.co/RTUGOmO1Da
@hmmmcurious https://t.co/rIGs8iqgr3
@Jackie1111 @BowTiedVitamins For what its worth small clinical study pub med https://t.co/MYRpAsntd8.
@1972RanPar I would never do that! Here is that NIH study I mentioned. https://t.co/HuvawsFuxE
@drlipid Have you seen this study and what do you think of it? https://t.co/eXI1eQUPV4
Frontiers | Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants https://t.co/LVDmKuAKXX
@Dr_Red_Gamer I take 12,000 units daily, zero issues, zero side effects. Also decreases plaques in arteries. https://t.co/feDuscZ2KI
@ketofan1000 @jtsses @drpablocorral On atherosclerotic plaque clearance, clinical study with over 1000 participants: https://t.co/YnMKvNnUeN
@RIBI_isking @Thermobolic A combination of nattokinase and K2 works synergistically to reduce plaque. Study is here: https://t.co/2JOazjiYc6
RT @CovidConfusion: @kacdnp91 1062 subjects "Co-administration of vitamin K2 and aspirin with NK produced a synergetic effect. No noticeab…
@JacobGearhart9 @DonnaVande64310 @MdBreathe And intermittent fasting (skip breakfast) or low glocose- low carbohydrate diet to starve the hijacked cells. About nattokinase: https://t.co/2ktedJoNvq
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
@BetsyGoesGlam In the Chen et al study (doi: 10.3389/fcvm.2022.964977) NK was used along with aspirin, with no adverse effects reported I don't see any recommendation in the trials that it be taken with food or on an empty stomach
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
Here’s the link to one medical study about Nattokinase: https://t.co/6iUJznPTuN
Frontiers | Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants https://t.co/tsTNHI7l9B
Frontiers | Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants. Really interesting study. https://t.co/BnlXrMviRq
RT @drmikehart: Study link
RT @drmikehart: Study link
Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants #MECFS #LongCovid pubmed.ncbi.nlm.nih.gov/36072877/
pubmed.ncbi.nlm.nih.gov/36072877/ "Our findings provide clinical evidence on the effective dose of NK in the management of cardiovascular disease and challenge the recommended dose of 2,000 FU per day."
pubmed.ncbi.nlm.nih.gov/36072877/ "Some lifestyle factors and the coadministration of vitamin K2 and aspirin lead to improved outcomes in the use of NK."
pubmed.ncbi.nlm.nih.gov/36072877/ "In conclusion, our data demonstrate that atherosclerosis progression and hyperlipidemia can be effectively managed with NK at a dose of 10,800 FU/day." "The lower dose of 3,600 FU per day is ineffective." "The dose of 10,800 FU/day is safe and well tolerated."
pubmed.ncbi.nlm.nih.gov/36072877/ "We found that NK at a dose of 10,800 FU/day effectively managed the progression of atherosclerosis and hyperlipidemia with a significant improvement in the lipid profile."
pubmed.ncbi.nlm.nih.gov/36072877/ "Regular exercise further improved the effects of NK." "Co-administration of vitamin K2 and aspirin with NK produced a synergetic effect." "No noticeable adverse effects associated with the use of NK were recorded."
pubmed.ncbi.nlm.nih.gov/36072877/ "In this clinical study involving 1,062 participants, our objective was to examine the efficacy of NK in atherosclerosis and hyperlipidemia and safety at the dose of 10,800 FU/day after 12 months of oral administration."
pubmed.ncbi.nlm.nih.gov/36072877/ "A significant reduction in the thickness of the carotid artery intima-media and the size of the carotid plaque was observed." "The improvement rates ranged from 66.5 to 95.4%."
pubmed.ncbi.nlm.nih.gov/36072877/ "Nattokinase (NK), known as a potent fibrinolytic and antithrombotic agent, has been shown to have antiatherosclerotic and lipid-lowering effects." "However, data on human clinical studies are limited."
pubmed.ncbi.nlm.nih.gov/36072877/ "NK was found to be ineffective in lowering lipids and suppressing atherosclerosis progression at a dose of 3,600 FU/day." "The lipid-lowering effect of NK was more prominent in subjects who smoked, drank alcohol, and subjects with higher BMI."
pubmed.ncbi.nlm.nih.gov/36072877/ "Various factors, including lower doses that influence NK pharmacological actions, were also investigated."
RT @drmikehart: Study link
RT @drmikehart: Study link
Study link
@GarbageLiberty @cremieuxrecueil Ask grok. And here’s the PubMed. https://t.co/2JOazjiqmy
La nattokinasa, es un suplemento prometedor para reducir riesgo cardiovascular. Chen H et al. Effective management of atherosclerosis and hyperlipidemia with nattokinase: A clinical study with 1,062 52 participants. Front Cardiovasc Med. 2022 doi: 10.3389/fcvm.2022.964977 2 https://t.co/Od5bv5kODe
RT @Cernovich: @chamath I settled in on nattokinase rather than a statin, but that's much disputed and debated. Cardiac discourse gets hott…
Statins cause dementia but this is better. https://t.co/giCoWomhSZ
@mlach22 Hi Marc: Go here: https://t.co/tVTfb3To1y
RT @BowTiedPhys: [1]: https://t.co/lSd4MOq3Xw [2]: https://t.co/BoiQdr37ux
[1]: https://t.co/lSd4MOq3Xw [2]: https://t.co/BoiQdr37ux
@LOVEJESUS_USA @Marion436842126 Sorry, screwed up the link. Here it is: https://t.co/lwUhZ9kPJG
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
@DuaneBiggs https://t.co/6vVmBW9pNp
RT @Cernovich: @chamath I settled in on nattokinase rather than a statin, but that's much disputed and debated. Cardiac discourse gets hott…
RT @Cernovich: @chamath I settled in on nattokinase rather than a statin, but that's much disputed and debated. Cardiac discourse gets hott…
@chamath I settled in on nattokinase rather than a statin, but that's much disputed and debated. Cardiac discourse gets hotter than Israel Palestine. https://t.co/zL6vh9TWq3
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
@DuaneBiggs https://t.co/NX9nJhXehV I'm using 500 micrograms of k27 and I like it
https://t.co/NX9nJhXehV
@MMG737 @grok 代Grok手动来贴:https://t.co/5pPrz38RLz
@BowTiedGrandma @PGC1a_RB https://t.co/ALFBT4tuam
@thewhitetie77 @Cernovich No prob. https://t.co/mHL3mffKqi
@redframed1776 @Juliesnark1731 Vitamin K2 and nattokinase can help move arterial plaque out of the arteries https://t.co/jqLmhSAKVA
If you were testing the effect of nattokinase on carotid plaque why wouldn’t you randomize patients with plaque to nattokinase or placebo? This is a really strange way to do a trial that doesn’t inspire confidence in the researchers https://t.co/ABLdAVBf1D https://t.co/1bNBAaQK6K
RT @DrPaulMason: Doses below 3,600 FU/day were deemed ineffective in limiting atherosclerosis progression. Regular exercise was associated…
RT @KahunaLynn: @JB_Slear Here's another interesting study of Nattokinase https://t.co/CMhmHGn0Pi
@JB_Slear Here's another interesting study of Nattokinase https://t.co/CMhmHGn0Pi
I believe the proper dose is higher, this study used 10,800 (still easily done and fairly inexpensive) https://t.co/r33b7FY7ov https://t.co/YsuAPyyhR7
RT @kineticquant: @GPG_8888 @Cernovich Certainly, here’s a couple links to the one I recently read. I think 2-4k is still beneficial but it…
@GPG_8888 @Cernovich Certainly, here’s a couple links to the one I recently read. I think 2-4k is still beneficial but it scales up at a curve when you hit 8-10k https://t.co/2VBOZknYN6 Same study: https://t.co/nASA5iS3hm
@MlogicGr8Again @Fynnderella1 @MdBreathe @MakisMD @delbigtree @P_McCulloughMD I would take at least 12,000 IU of nattokinase. I've been cleaning my veins this way for a year. Before I started I had a 50% blocked carotid artery. Copper may also help against PrPSc. 12,000 IU seems like a safe dose. https://t.co/NgLylzJK2i
@MlogicGr8Again @Fynnderella1 @MdBreathe @MakisMD @delbigtree @P_McCulloughMD Minimal doses: 10.800 FU / day Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants https://t.co/NgLylzJK2i https://t.co/p4kidRexTm
RT @DrPaulMason: Doses below 3,600 FU/day were deemed ineffective in limiting atherosclerosis progression. Regular exercise was associated…
Doses below 3,600 FU/day were deemed ineffective in limiting atherosclerosis progression. Regular exercise was associated with an enhanced response to nattokinase, and no notable adverse effects were identified (https://t.co/nA9ospxBqj).
@SPusnar Kaj vam pove ta znanstvena objava? Ni edina na to temo. Ja, ustrezne doze so ključne, pri vsem. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants https://t.co/NgLylzJK2i https://t.co/p4kidRexTm
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
RT @Cernovich: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participan…
Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants https://t.co/zL6vh9TWq3
RT @WaxlNakamoto: @Cernovich One reason why it's great. Also should be high dose + use with K2 https://t.co/hfZhHJUem8
@Cernovich One reason why it's great. Also should be high dose + use with K2 https://t.co/hfZhHJUem8
@Cernovich Maybe saved my life. Mid 50s and Calcium score alrerady 55 in LDA. Got blood work with a 300 triglyceride #. W/in the week Cerno posted article on NK effects. https://t.co/fDGbnwgAKM Started taking 12,000 FU immediately. New BW Trig 82 Total Chl 117 LDL 58 VLDL 16. 10mg crestor.
@DrSiyabMD I'll select the nattokinase door over the GLP-1 inhibitors door, thank you very much. https://t.co/jJrFdbX6BD
@drjohnm Off topic: I'd like to hear your thoughts on this study... https://t.co/jJrFdbX6BD
Nattokinaz klinik çalışmada uygun dozda kullanıldığında karotis plaklarını küçültüp, ateroskleroz ilerlemesini önledi. Ayrıca lipid düşürücü etkisi de buluna nattokinaz aspirin ile de sinerjistik etki gösterdi. https://t.co/tSJcBD4ESp
@bryan_johnson @ezrainc Nattokinase and K2 are promising too and worth looking at https://t.co/b1qRoFVfYD https://t.co/hfZhHJUem8
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
@MRothbergMD https://t.co/ZIkouEGSGc https://t.co/PuEmwDBLT1 https://t.co/NLVFa5HiuI https://t.co/SA71arH2Re
@CaryKelly11 Here’s a good study to start with… https://t.co/feDuscZ2KI
@legallymom2 Our medical system would rather give out statins like candy on Halloween and cross fingers. It makes no sense. I can't tolerate statins. But there's promising research on nattokinase to reduce arterial blockage. That's what I take. https://t.co/Hw2IbKpJzc
@HansChr52239198 We're in a bit of an evidence void with how long patients should continue a protocol. However in cardiovascular health context, studies suggest > 10,000 FU/d for several months seems safe, e.g. this study for 12 months: https://t.co/5LcWSilBSd
@ThrillaRilla369 Here’s a recent study on effectiveness -1062 people with arterial sclerosis meaning cardiovascular disease. Year Long study. Amazing results. https://t.co/MrvCDpawnA
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
@LDLSkeptic Chen H, Chen J, Zhang F, Li Y, Wang R, Zheng Q, Zhang X, Zeng J, Xu F, Lin Y. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants. Front Cardiovasc Med. 2022 Aug 22;9:964977. doi: 10.3389/fcvm.2022.964977
@WillyDisavowed @DudespostingWs Here you go dumb fuckface. https://t.co/DSMCE339xJ
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
RT @Mangan150: Patients who took nattokinase for a year REVERSED carotid artery plaque and thickness by 36 and 22% respectively. Lipid pro…
Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants https://t.co/gU8TNNIoPf
RT @drmikehart: 10,800 FU of Nattokinase per day for 12 months REVERSED carotid artery plaque thickness by 36%! Commonly used doses of Nat…
RT @dr_chives: @richardhoangbui Definitely a nothingburger. Always trust degen twitter https://t.co/7FPgKVk64X
@richardhoangbui Definitely a nothingburger. Always trust degen twitter https://t.co/7FPgKVk64X
@doption may want to up that nattokinase dose to 10800fu https://t.co/FwOKeQ1al6
@BowTiedGatorDDS @e_cdalton 10800 FU for 12 months in unhealthy subjects seem safe: https://t.co/fJO6Ymb1oT I've also been doing 12kFU for a year, never had the slightest bleeding issue, but my vax spike in serum and PBMCs got fucking nuked. Good stuff.
RT @keisuke4713: NK1,062人⇒アテローム性動脈硬化の進行と高脂血症 https://t.co/JG0ZlWdHL6 NK10,800FUで安全問題報告無し TG、TC、LDL⬇️ HDL-C15.8%⬆️ 喫煙者、飲酒者、BMI⬆️でより顕著 定期運動…
https://t.co/07Zg1fDTUh
@ImmunoGangsta https://t.co/jJrFdbWyM5
@NestCommander @JackDor79489806 @CoyoteSanctuary @BlackTomThePyr8 @HouseLyndseyRN In humans. https://t.co/jJrFdbWyM5
China: *Nattokinase (subtilisin) is a potent fibrinolytic and anti-thrombotic agent *It also has anti-atherosclerotic and anti-dyslipidemic effects *At a dose of 10,800 FU/day, it effectively improved atherosclerosis and hyperlipidemia *Add MK-7, fish oil? https://t.co/NEzJ70vyIn
RT @Cernovich: I take 10,000 units a day NOT A RECOMMENDATION. talk to your doctor and as always, get blood work done. https://t.co/zL6v…
@MohammedAlo Any thoughts on this study? https://t.co/oS2n11armX
RT @Cernovich: I take 10,000 units a day NOT A RECOMMENDATION. talk to your doctor and as always, get blood work done. https://t.co/zL6v…
RT @Cernovich: I take 10,000 units a day NOT A RECOMMENDATION. talk to your doctor and as always, get blood work done. https://t.co/zL6v…
RT @Cernovich: I take 10,000 units a day NOT A RECOMMENDATION. talk to your doctor and as always, get blood work done. https://t.co/zL6v…
RT @Cernovich: I take 10,000 units a day NOT A RECOMMENDATION. talk to your doctor and as always, get blood work done. https://t.co/zL6v…
RT @Cernovich: I take 10,000 units a day NOT A RECOMMENDATION. talk to your doctor and as always, get blood work done. https://t.co/zL6v…
RT @Cernovich: I take 10,000 units a day NOT A RECOMMENDATION. talk to your doctor and as always, get blood work done. https://t.co/zL6v…
I take 10,000 units a day NOT A RECOMMENDATION. talk to your doctor and as always, get blood work done. https://t.co/zL6vh9TWq3
https://t.co/HL7CXK9hjS https://t.co/uI796s36GZ
@freespiritcherc @DrKristieLeong https://t.co/56sa1XINte
Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants https://t.co/56sa1XINte
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
https://t.co/Jj9WYeZLc6
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
RT @DRobertaLacerda: Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participante…
Manejo eficaz do progresso da aterosclerose e hiperlipidemia com natoquinase: Um estudo clínico com 1.062 participantes - PubMed https://t.co/TzY8P12owe
@SrslyWrong Nattokinase as antithrombolytic: https://t.co/SQf094fbpm https://sci dash hub dot se/https://t.co/2aTsnrJnml Natto in vitro spike protein study: https://t.co/FyIusEvPBy PEA+Lut anosmia and brain fog: https://t.co/bLOJR3Vvwv https://t.co/yb0QQTHoFU https://t.co/fiuRKXgBoi
@nuclearmed23 @MohammedAlo @SABOURETCardio How about this one…https://t.co/WO8ADVEusx
RT @SteveAntenucci1: @holmanm @RN4Truth https://t.co/jCFRbGHfDw
@holmanm @RN4Truth https://t.co/jCFRbGHfDw
@MoronicHeadline Belay my last, 10,800, not 11,000. https://t.co/n4YOtwxC6p. https://t.co/i8XhKR0fIb
@agingdoc1 @SciReports If you can't find natto or do not like the taste, you can use a supplement to get the same effect: https://t.co/DpTPSF8HMw Some other relevant studies: https://t.co/H6iOP2Cle6… https://t.co/TAnQiFzxHr… https://t.co/6ZIcuFZG4w Natokinase, the enzyme created by the
@michaelpollan If you can't find natto or do not like the taste, you can use a supplement to get the same effect: https://t.co/zvNJ3KT0dM Some other relevant studies: https://t.co/DVyx9Hu1e9 https://t.co/2V9ck5kqAw https://t.co/5W29bJnY1h Natokinase, the enzyme created by the bacterial
@LadyLibertyinAZ @holmanm https://t.co/jCFRbGHfDw
Changed my anti-atherosclerosis supp stack (upped the Natto dose from 2k to 10kFU). Waited to mention it, to see if I noticed any side affects. None so far. - Cholrem CAVADEX - Oral Alpha-Cyclodextrin - Nattokinase 10.000+ FU/day & Vitamin K2 MK7 (https://t.co/t0G0yWsTOs) https://t.co/OcZ5gJPIJO
@Michell87463246 @annvandersteel https://t.co/gkk5p5D1u2 Do what you will with this to determine if your nattokinase dosage was enough, and can get your doctor's opinion.
@RealDrJaneRuby @Joethemachine1 @annvandersteel https://t.co/gkk5p5D1u2
@RealDrJaneRuby @Joethemachine1 @annvandersteel https://t.co/gkk5p5D1u2 https://t.co/qR0UlxsOaW Use these to make up your own mind about dosage and effectiveness for yourselves
@VictorFromDE @isuckatwife Look into nattokinase at a 10000 FUs daily dosage. Helps boost bodies own ability to break up blood clots and is a declotting agent itself. Not medical advice, but check it out, as it also helps with arthersclerosis https://t.co/gkk5p5D1u2
Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 p… https://t.co/zyVUGkQnQY
RT @DoctoraPrego: La #Nattokinasa (#NK) se ha convertido en estrella para la salud cardiovascular. Pacientes e Investigaciones muestran que…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: #NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adv…
RT @Aguirre1Gustavo: NATOQUINASA Estudio señala que: 10,800 UF/d es una dosis efectiva y segura para tratar la aterosclerosis No se registr…
RT @Aguirre1Gustavo: NATOQUINASA Estudio señala que: 10,800 UF/d es una dosis efectiva y segura para tratar la aterosclerosis No se registr…
#NATTOKINASE Study indicates that: 10,800 FU/day is an effective and safe dose to treat atherosclerosis No notable adverse effects recorded in 12 months of use. Indicated together with Aspirin 100mg/d it has a synergistic effect also with Vitamin K 180ug/d https://t.co/dlmxg2UYGH https://t.co/yOIg2YWCmG
NATOQUINASA Estudio señala que: 10,800 UF/d es una dosis efectiva y segura para tratar la aterosclerosis No se registraron efectos adversos notables en 12meses de uso Indicado junto con Aspirina 100mg/día tiene un efecto sinérgico también con Vit K 180ug/d https://t.co/dlmxg2UqR9 https://t.co/zxFMBBb4gr